SCHEMBL21636277

SCHEMBL21636277

CNCCN(C)C(=O)c1ccc(-n2nc(C)c3c2-c2ccsc2CC3)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GRIA2 P42262 3/20 0.37
▸ CYP2C9 P11712 2/20 0.37
▸ CYP2D6 P10635 2/20 0.37
▸ CYP2C19 P33261 1/20 0.35
▸ SHMT2 P34897 2/20 0.35
▸ CACNA2D1 P54289 1/20 0.35
▸ AR P10275 1/20 0.34
▸ CYP1A2 P05177 1/20 0.33
▸ RAD52 P43351 1/20 0.33
▸ PIK3CA P42336 1/20 0.33
▸ MTOR P42345 1/20 0.33
▸ PIK3CG P48736 1/20 0.33
▸ ALDH1A1 P00352 2/20 0.32
▸ POLB P06746 2/20 0.32
▸ MAPT P10636 1/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32
▸ CCNA2 P20248 4/20 0.32
▸ CDK2 P24941 4/20 0.32
▸ CCNA1 P78396 4/20 0.32
▸ LMNA P02545 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21625155 0.85 SHMT2 (0.42) SHMT2PIK3CAPIK3CG
SCHEMBL21625146 0.83 CACNA2D1 (0.41) GRIA2CYP2C9CYP2C19SHMT2CACNA2D1
SCHEMBL21636250 0.75 F10 (0.34) SHMT2CCNA2CDK2CCNA1
SCHEMBL21625053 0.75 NR1H4 (0.46) SHMT2CACNA2D1PIK3CAPIK3CGALDH1A1
SCHEMBL21625090 0.73 SHMT2 (0.43) SHMT2PIK3CAPIK3CG
SCHEMBL21636241 0.73 HIF1A (0.43) CYP2C9CYP2C19SHMT2CYP1A2PIK3CA
SCHEMBL21625205 0.71 SHMT2 (0.42) GRIA2CYP2C9CYP2C19SHMT2CACNA2D1
SCHEMBL21625082 0.71 PIK3CD (0.46) GRIA2CYP2C9CYP2C19SHMT2CACNA2D1
SCHEMBL21625120 0.70 SHMT2 (0.43) SHMT2RAD52PIK3CAPIK3CGPOLB
SCHEMBL21625073 0.69 SHMT2 (0.48) SHMT2RAD52PIK3CAPIK3CGPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020016315-A1 FUSED DIHYDROINDAZOLE DERIVATIVES HAVING MULTIMODAL ACTIVITY AGAINST PAIN ESTEVE PHARMACEUTICALS, S.A. (ES) 2020-01-23 — — WO disclosed
Send feedback